Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New
NSE India 1870 (0%)Tata Capital 925 (-7%)Essar Oil 1875 (4.2%)SBI Mutual Fund 2675 (0%)Swiggy IPO 435 (0%)HDB Financial 1125 (-2.2%)Swiggy CCPS 574410 (0%)Capgemini Technology 14000 (0%)Hexaware IPO 1020 (0%)NSDL 990 (0%)OYO 56 (1.8%)Hero Fincorp 1925 (0%)AB Inbev Sabmiller 350 (0%)CIAL 460 (-1.7%)Care Health Insurance 186 (0%)HDFC Securities 10750 (0%)BOAT 1675 (0%)VIkram Solar Ltd 440 (-4.3%)Motilal Oswal 18 (-10%)Indian Potash 3175 (0%)Manjushree Technopack 950 (0%)Electrosteel Steel Ltd 46 (0%)Signify Innovations 1425 (0%)Sterlite Power 625 (-7.4%)Shriram Life Insurance 400 (0%)Elcid Investments 350000 (0%)Carrier Airconditioning 595 (-4.8%)CSK 198 (5.3%)Pharmeasy 9 (-10%)Orbis Financial 465 (-2.1%)Fincare Small Finance Bank 260 (0%)Philips India 945 (0%)Otis Elevator 4250 (0%)Bharat Bank 16800 (-5.6%)Kurlon Ltd 1250 (0%)MSEI 8.5 (-5.6%)ESDS Software 435 (-13%)Onix Renewable 22800 (0%)Merino Industries 3350 (-2.9%)Philips Domestic Appliances 585 (-6.4%)Indofil Industries 1295 (-6.5%)Veeda Clinical Research Limited 535 (1.9%)Studds 695 (-4.1%)Lava 46 (0%)Polymatech Electronics Pvt Ltd 58 (-9.4%)Matrix Gas and Renewables 765 (-3.8%)Kurlon Ent 550 (0%)Mohan Meakin 2300 (-2.1%)Kannur International Airport 138 (0%)GKN Driveline 1425 (0%)Fino Paytech Limited 135 (-4.9%)Lakeshore Hospital 135 (0%)Goodluck Defence 268 (-2.5%)Spray Engineering Devices 565 (0%)NCDEX 235 (0%)AV Thomas 22000 (0%)C2C Advanced systems 595 (0%)Bira 498 (-3.3%)Greenzo Energy Pvt Ltd 695 (-0.7%)Apollo Green Energy 315 (-9.5%)Ring Plus 695 (0%)Schneider Electric 675 (0%)Maharashtra Knowledge Corporation MKCL 450 (0%)NCL Buildtek 298 (0%)Urban Tots 72 (5.9%)Martin and Harris Lab 850 (0%)India Carbon ltd 1175 (0%)AVPL 60 (0%)Empire Spices and Foods ltd 585 (0%)Resins and Plastic 650 (0%)ICEX 5 (-9.1%)PolicyX 57 (0%)RRP S4E Innovation 285 (-6.6%)Maxvalue Credits And Investments 7 (0%)Ecosure Pulpmolding 56 (0%)Quality Enviro 1350 (0%)Assam Carbon Products 440 (0%)Ramaraju Surgical Cotton 305 (7%)ICL Fincorp 26 (0%)Amol Minechem Ltd 1100 (0%)Bazar India 25 (0%)Silverline Technologies Ltd 12 (0%)ACS Technologies 46 (0%)Market Simplified 36 (0%)Madbow 35 (0%)

15 Days Price Change

Veeda Clinical Research Limited Unlisted Share

Veeda Clinical Research Limited Unlisted Share

₹535 0 | 0%

Market Cap ₹ 2830Cr.

Current Price ₹ 535

Lot Size 100

52W High ₹ 600

EPS 8.02

P/B 6.1

Face Value 2

Debt to Equity 0.1

Stock P/E 66.7

Book Value ₹ 87.5

Company

52W Low ₹ 525

Demat Account Both

ISIN INE01HQ01026

Valuation

No. of Shares 5.29Cr.

Veeda Clinical Research Limited Unlisted Share Price

| |

Price

About Veeda Clinical Research Limited Unlisted Shares Inc. Year: 2004Industry: Medical Equipment/Supplies/Accessories

Veeda Clinical Research Limited is a prominent Contract Research Organization (CRO) based in India, specializing in providing clinical research services to the global pharmaceutical and biotechnology industries. Established in 2004, Veeda offers a comprehensive range of services including bioavailability and bioequivalence studies, phase I-IV clinical trials, clinical data management, pharmacovigilance, and statistical analysis. With state-of-the-art facilities and adherence to international regulatory standards, Veeda ensures high-quality, ethical, and reliable research outputs. The company is committed to advancing healthcare through innovation, scientific excellence, and strong client partnerships, making it a trusted partner for drug development and regulatory submissions worldwide.

Veeda Clinical Research Limited (CRO)'s Unlisted Share Price are updated on our website on a daily basis, to stay updated with the share price you can visit our website every two days or register with us to get daily updates on WhatsApp.

Read More..

Research & News

Discussion Board

Vasu Moradiya 1 months

will veeda get listed soon?

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Financial Data (in cr.)

FY22 FY23 YOY % FY23 CAGR % FY23
Net Sales 288 409.6 42.2 42.2
Total Income 293.1 420.2 43.4 43.4
Net Profit 50.5 42.4 -16 -16
Shareholder Funds 437.3 462.9 5.9 5.9
Total Assets 677.5 734.8 8.5 8.5
EPS 9.54 8.02 -15.9

Financial Docs

Type Period/Date Document
Annual Report 2023-03

Veeda Clinical Research Limited Unlisted Shares: FAQs

1. Is trading in Veeda Clinical Research Limited (CRO)'s unlisted shares legal in India?

Yes trading in unlisted shares is undoubtedly legal in India. The trading takes place in the over-the-counter market through various platforms like Sharescart.com.

2. Is unlisted shares regulated by SEBI?

No, SEBI does not regulate the unlisted share market but certain rules and regulations of SEBI are applicable in the unlisted market space as well, such as, the DP charges for each transaction, stamp duty, lock-in period and more.

3. Where can I get the best Veeda Clinical Research Limited (CRO) unlisted share price?

You will get the best price for Veeda Clinical Research Limited (CRO) and a hassle-free buying experience only on Sharescart.com platform.

4. How can I buy Veeda Clinical Research Limited (CRO)'s unlisted shares?

Veeda Clinical Research Limited (CRO)'s unlisted shares can be easily purchased at Sharescart.com by following a few easy steps. Given below are the steps involved in the buying of these shares:

Step 1 - Confirm the number of shares you want to buy/sell of at the trading price.

Step 2 - Submit necessary documents like the Client Master Report (CMR) or additional documents (PAN, canceled cheque) if using a secondary bank account.

Step 3 - Transfer the trade amount to the account details shared by Sharescart.com.

Step 4 - Shares of will reflect in your Demat account within 24 hours after full payment (subject to holidays).

5. How can I sell Veeda Clinical Research Limited (CRO) unlisted shares?

Veeda Clinical Research Limited (CRO)'s unlisted shares can be easily sold at Sharescart.com by following a few easy steps. Given below are the steps involved in the of selling of these shares:

Step 1- Confirmation on the number of shares you want to sell of Veeda Clinical Research Limited (CRO) and at what price you want to sell.

Step 2- At Sharescart, we will find a suitable buyer for you according to your requirements and if you accept the trade we will move on to the transfer and the payment aspect of the trade.

Step 3- The Sharescart representative will provide you with the Demat account details to transfer your Veeda Clinical Research Limited (CRO) shares. They will also notify you about the additional details required from your end before the transfer of shares such as client master copy, delivery instruction slip, and more.

Step 4- Once the transfer is complete, the payment would be credited to your bank account within 24 hours, depending on the holidays.

6. What is the minimum ticket size for investment in Veeda Clinical Research Limited (CRO) unlisted shares?

Over the years, the minimum ticket size for investment has dropped as more and more people have started investing in the Unlisted market. Currently, the minimum ticket size for Veeda Clinical Research Limited (CRO) is between 48,000 to 59,000.

7. How to check if Veeda Clinical Research Limited (CRO) shares are credited to my account?

Brokers or dealers provide you with a trading facility means you can buy and sell shares with your broker but when you buy shares the Depository holds your shares. There are mainly two depositories NSDL and CDSL.

If you want to check your shares in NSDL and CDSL you need to download the application (NSDL Speede App or CDSL myeasi).

  • You need to download the Application.
  • Login or Register yourself.
  • Fill in your DP Id and Client Id (NSDL DP Id starts with IN and CDSL DP & Client Id in numeric).
  • After registration, log on to your account and go to Dashboard.
  • You can see all your holding (Listed, Unlisted, Mutual Fund) there.

8. What will be the tax bearing on Veeda Clinical Research Limited (CRO)?

The taxation on the Veeda Clinical Research Limited (CRO) shares may vary depending on 2 Factors:

  • Short-term capital or long-term capital.
  • Pre-IPO stage (unlisted shares) or Post-IPO stage (listed shares)

Short-term capital

Unlisted shares - In unlisted shares, the taxation of short-term capital gain i.e. less than 24 months is taxable according to the investor's income tax slab.

Listed Shares - In listed shares, the taxation for short-term capital gains i.e. less than 12 months is at 20% without indexation benefits.

Long-term capital

Unlisted shares - The taxation for long-term capital gain i.e. more than 24 months is taxable at 12.5% without indexation benefits.

Listed Shares - The taxation for long-term capital gains i.e. more than 12 months is at 12.5% after an exemption of 1.25 lakh.

9. What is the lock-in period of Veeda Clinical Research Limited (CRO) shares?

According to the current rule issued by SEBI last year in August 2021, the lock-in period is brought down from 1 year to 6 months. This was done to entice more investors to invest their money in pre-IPO companies and startups. The lock-in period of Veeda Clinical Research Limited (CRO) varies depending on which type of investor you are:

  • Foreign Venture Capital Investor - These investors have a lock-in period of 6 months from the procurement date of Veeda Clinical Research Limited (CRO) shares.
  • Alternative Investment Funds II - These investors don't have to serve any lock-in period.
  • Other investors - These investors include body corporate, retail, high net-worth individuals. The lock-in period for them is 6 months from the date of listing of Veeda Clinical Research Limited (CRO) enlisted shares.

10. How to check Veeda Clinical Research Limited (CRO) unlisted share price daily?

You can check daily share prices of companies on our website or register with us using your phone number where you will get daily whatsapp updates on company news and other essential informations.

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)